The HALT Study is a double blinded, randomized, placebo-controlled trial to determine the effectiveness of TRIV202 in managing left ventricular hypertrophy associated with feline subclinical hypertrophic cardiomyopathy (HCM) over 12 months. The study will be conducted at various cardiac centers across the US with more to be added over time. It will aim to enrol 300 cats.
Where is HALT taking place?
The HALT Study will be taking place in the below cardiac care centers across the US, with more to be added over time. Select the site closest to you and if you don't see one in your City/State select other and fill out the general form and you will be notified of any new sites!
Study Sites
Rohnert Park, California
Sacramento, California
San Juan Capistrano, California
South Bay Los Angeles, California
West Los Angeles, California
West Palm Beach, Florida
Louisville, Kentucky
Frederick, Maryland
Lawrence, Massachusetts
Woburn, Massachusetts
Manchester, Missouri
Reno, Nevada
Portsmouth, New Hampshire
Charlotte, North Carolina
Akron, Ohio
Greenville, South Carolina
Fairfax, Virginia
Richmond, Virginia
Everett, Washington
Waukesha, Wisconsin
Register your interest for The HALT Study below
No site in your area/country? Fill in our interest form to receive future updates on feline HCM research in the Rest of World.
